MassDevice.com +5 | The top 5 medtech stories for June 30, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. LivaNova wins FDA nod for VNS therapy neurostim for young epilepsy patients
LivaNova said today it won FDA approval of its Vagus Nerve Stimulation Therapy system for patients as young as 4 years of age with partial onset seizures that are refractory to antiepileptic medications.
The London-based company touted that with the clearance, its VNS Therapy system is the only FDA-approved device for drug-resistant epilepsy in the pediatric population. Previously, the device was only approved for patients ages 12 and older. Read more
4. Report: Intuitive Surgical won’t sell in Pakistan until da Vinci devices back on line
Intuitive Surgical is reportedly refusing to sell any more of its da Vinci robot-assisted surgery platforms in Pakistan until the two it’s already got on the market there are brought back on line.
The Sindh Institute of Urology & Transplantation in Karachi asked to acquire a da Vinci system, according to The News of Pakistan, but Intuitive Surgical refused until a pair of disused da Vincis at other hospitals in Karachi are made operable again. Read mo...
Source: Mass Device - Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
More News: Brain | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Epilepsy | France Health | Heart | Hong Kong Health | Hospitals | Lawsuits | Legislation | Marketing | Medical Devices | Mergers and Aquisitions | Neurology | Neurosurgery | Pakistan Health | Pediatrics | Training | Transplants | Universities & Medical Training | Urology & Nephrology | Vagus Nerve Stimulation Therapy